BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23325341)

  • 1. Decreased expression and prognostic role of mitogen-activated protein kinase phosphatase 4 in hepatocellular carcinoma.
    Liu J; Ni W; Xiao M; Jiang F; Ni R
    J Gastrointest Surg; 2013 Apr; 17(4):756-65. PubMed ID: 23325341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressed MKP-1 is an independent predictor of outcome in patients with hepatocellular carcinoma.
    Tsujita E; Taketomi A; Gion T; Kuroda Y; Endo K; Watanabe A; Nakashima H; Aishima S; Kohnoe S; Maehara Y
    Oncology; 2005; 69(4):342-7. PubMed ID: 16293973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic significance of p21-activated kinase 6 in hepatocellular carcinoma.
    Chen H; Miao J; Li H; Wang C; Li J; Zhu Y; Wang J; Wu X; Qiao H
    J Surg Res; 2014 Jun; 189(1):81-8. PubMed ID: 24576777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance.
    Gao ZF; Wu YN; Bai ZT; Zhang L; Zhou Q; Li X
    Oncol Rep; 2016 Dec; 36(6):3427-3435. PubMed ID: 27805249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma.
    Zhang XF; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Wang DD; Jiang SS; Zheng HX; Lv L; Chen CL; Zhang HX; Xia JC
    Mol Carcinog; 2016 Jan; 55(1):64-76. PubMed ID: 25557723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma.
    Jin H; Zhang Y; You H; Tao X; Wang C; Jin G; Wang N; Ruan H; Gu D; Huo X; Cong W; Qin W
    Sci Rep; 2015 Jun; 5():10466. PubMed ID: 26099564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential.
    Uranbileg B; Enooku K; Soroida Y; Ohkawa R; Kudo Y; Nakagawa H; Tateishi R; Yoshida H; Shinzawa S; Moriya K; Ohtomo N; Nishikawa T; Inoue Y; Tomiya T; Kojima S; Matsuura T; Koike K; Yatomi Y; Ikeda H
    Int J Cancer; 2014 May; 134(9):2189-98. PubMed ID: 24174293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
    Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
    Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.
    Zhang Z; Meng G; Wang L; Ma Y; Guan Z
    Mol Med Rep; 2016 Jul; 14(1):254-62. PubMed ID: 27177166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
    Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
    Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of methyl methansulfonate and ultraviolet-sensitive gene clone 81 (Mus81) is correlated with a poor prognosis in patients with hepatocellular carcinoma.
    Wu F; Liu SY; Tao YM; Ou DP; Fang F; Yang LY
    Cancer; 2008 May; 112(9):2002-10. PubMed ID: 18327812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
    Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
    BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
    J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.